argenx SE announced that at the Annual General Meeting of shareholders held on May 7, 2024 Dr. Brian L. Kotzin has been appointed as non-executive director to the Board of Directors for a term of four years. Dr. Kotzin brings broad medical and scientific research and development experience to the Board, supporting the Company?s innovation mission across therapeutic areas.
Market Closed -
Other stock markets
|
After market 11:58:00 am | |||
347.4 EUR | +1.97% | 345.1 | -0.66% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.14% | 21.96B | |
+14.97% | 118B | |
+13.00% | 106B | |
-3.40% | 24.28B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-16.97% | 15.56B | |
+5.62% | 13.63B | |
+28.45% | 12.27B | |
+85.53% | 8.87B |
- Stock Market
- Equities
- ARGX Stock
- News argenx SE
- Argenx SE Appoints Dr. Brian L. Kotzin as Non-Executive Director to the Board of Directors